DCP Immunology Interest Group (IIG) Seminar Series
This talk will summarize the field of personalized cancer vaccines, discuss key challenges and future directions, and highlight recent clinical trial results. Dr. Wu will present novel approaches to antigen discovery and examine tumor-immune microenvironment interactions in cancer vaccination.
Key information
- Date: Wednesday, September 9, 2026
- Time: 2:00pm EDT to 3:00pm EDT
- Location: Virtual
Speaker
Catherine J. Wu, MD
Professor of Medicine and Chief, Division of Stem Cell Transplantation and Cellular Therapies
Dana-Farber Cancer Institute, Harvard Medical School
Biography
Catherine Wu, MD, is a Professor of Medicine and Chief, Division of Stem Cell Transplantation and Cellular Therapies, at Dana-Farber Cancer Institute. She is a member of the National Academy of Medicine and the Association of American Physicians. She is also the 2024 recipient of the prestigious Sjoberg Award. Wu received her MD from Stanford University School of Medicine, and completed her clinical training in Internal Medicine and HematologyOncology at Brigham and Women's Hospital and Dana-Farber. She joined the staff at DanaFarber in 2000. At Dana-Farber, she has initiated an integrated program of research and clinical activities that focuses on dissecting the basis of effective anti-tumor immunity. Wu's laboratory has focused on the use of genomics-based approaches to discover immunogenic antigen targets, to understand the molecular basis of therapeutic response and resistance, and to test personalized cancer vaccines across diverse malignancies.